Advertisement
Screener

Jade Biosciences, Inc. (JBIO) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Jade Biosciences, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Jade Biosciences, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $94.69M went out.
  • Fiscal year ended 2025-12-31: from investing, $247.01M went out.
  • Fiscal year ended 2025-12-31: from financing, $360.77M came in.
  • Fiscal year ended 2025-12-31: change in cash, $19.05M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldOtherNot split outChange in cash
2025-12-31-$94.69M-$247.01M$88.00K$189.11M$171.57M*$19.05M
2024-12-31-$71.20M$56.03M$23.94M$1.49M*$10.26M
2023-12-31-$56.78M$11.88M$44.89M$1.11M*$1.09M
2022-12-31-$39.12M$6.93M$617.00K-$31.80M
2021-12-31-$27.40M-$113.43M$126.94M$63.51M*$49.62M
2020-12-31-$7.86M$5.00K$8.91M*$1.06M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldOtherNot split outChange in cash
2026-06-30-$43.66M*-$97.63M*$1.53M*$191.99M*
2026-03-31-$24.08M-$8.47M$45.00K-$840.00K*-$33.35M
2025-12-31-$33.65M*-$98.16M*-$1.34M*$171.50M*
2025-09-30-$22.12M*-$148.71M*$0.00*
2025-06-30-$20.16M*-$12.99M*$191.31M*
2025-03-31-$18.76M$12.85M-$700.00K*-$19.46M
2024-12-31-$15.81M*$13.13M*$307.00K*-$3.08M*
2024-09-30-$6.80M$0.00$0.00*$94.77M*$87.97M
2024-06-30-$20.43M*$18.00M*$511.00K*$23.87M*
2024-03-31-$23.67M$8.83M$704.00K-$14.37M
2023-12-31-$14.80M*$5.65M*$0.00*
2023-09-30-$15.61M*-$13.13M*$0.00*
2023-06-30-$14.94M*$3.98M*$333.00K*$44.96M*
2023-03-31-$11.42M$15.38M$223.00K$4.17M
2022-12-31-$14.87M*$14.49M*$443.00K*
2022-09-30-$9.72M*$4.64M*$172.00K*
2022-06-30-$8.88M*$8.19M*
2022-03-31-$5.66M-$20.40M-$26.06M
2021-12-31-$13.09M*-$113.34M*-$250.00K*
2021-09-30-$6.53M*-$56.00K*$128.31M*
2021-06-30-$4.00M*$0.00*$54.51M*
2021-03-31-$3.77M-$40.00K$7.88M*$4.07M
2020-12-31-$2.88M*$0.00*
2020-09-30-$2.43M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Apnimed, Inc. (APMD)United States$0.899B
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
Cryoport, Inc. (CYRX)United States$0.881B-21.29
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03